Related Experiment Video
Updated: Dec 20, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19
Richard W Peck1, Daniel Weiner2, Jack Cook3
1Clinical Pharmacology, Pharma Research & Early Development, Roche Innovation Center, Basel, Switzerland.
Abstract:
Potential treatments for coronavirus disease 2019 (COVID-19) are being investigated at unprecedented speed, and successful treatments will rapidly be used in tens or hundreds of thousands of patients. To ensure safe and effective use in all those patents it is essential also to develop, at unprecedented speed, a means to provide frequently updated, optimal dosing information for all patient subgroups. Success will require immediate collaboration between drug developers, academics, and regulators.
More Related Videos
Related Concept Videos
Dosage Regimens: Designs and Approaches
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Dosage Regimen: Individualization
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dose Size and Dosing Frequency: Determination Methods
Drug Dosing: Geriatric Patients

